NCT04139863 (JuvePar) is a NA clinical trial of aMMP-8 chairside test in Periodontitis, Juvenile, sponsored by University of Helsinki.

Who is sponsoring NCT04139863?

NCT04139863 is sponsored by University of Helsinki.

What drugs are being tested in NCT04139863?

Interventions in NCT04139863: aMMP-8 chairside test.

What condition does NCT04139863 study?

NCT04139863 studies Periodontitis, Juvenile.

Is NCT04139863 still recruiting?

NCT04139863 is currently status unknown. Last updated 3 November 2020.

Last reviewed 2020-11-03 · How we verify

NCT04139863: JuvePar

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chairside Mouthrinse Test and Cost Effectiveness

Status unknown NA Last updated 3 November 2020

What this trial tests

NA trial testing aMMP-8 chairside test in Periodontitis, Juvenile in 200 participants. Status unknown.

Timeline

1 September 2017

Primary endpoint
2 November 2020

2 November 2020

Quick facts

Lead sponsor	University of Helsinki
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	200
Start date	1 September 2017
Primary completion	2 November 2020
Estimated completion	2 November 2020
Sites	1 location across Finland

Drugs / interventions tested

aMMP-8 chairside test

Conditions studied

Periodontitis, Juvenile — all drugs for Periodontitis, Juvenile →

Sponsor

University of Helsinki

Who can join

Adults 14 to 16, any sex, with Periodontitis, Juvenile. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to study whether participants at risk could be identified using an aMMP-8 chairside mouth rinse test and to study if oral health and health behaviour is linked to the test result in Finnish adolescents.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Helsinki trials

Trials by the same sponsor.

NCT07212361 — Infant Microbiota Restoration With Maternal Microbes · NA · recruiting
NCT06799988 — NutFinForce: The Impact of Digitally Delivered Lifestyle Performance Medicine Intervention on Defense Performance in Fin · not yet recruiting
NCT06464003 — Orthodontic Screening in Public Healthcare · recruiting
NCT06092372 — The Role of Genetics in Weight Loss · NA · completed
NCT06564675 — Accuracy of EEG Slow Wave Activity in Predicting Favourable Outcome in Patients With Hypoxic Brain Injury - A Substudy o · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04139863 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Helsinki
Last refreshed: 3 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04139863.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing